Hospital oncology costs among the cohort of elderly in an aging South-Eastern European nation

Mihajlo Jakovljevic, Marko Folic, Aleksandar Dagovic


Full Text



  • Lutz W, Sanderson W, Scherbov S. The coming acceleration of global population ageing. Nature 2008; 451: 716-9;
  • Yancik R. Population Aging and Cancer: A Cross-National Concern. Cancer J 2005; 11: 437-41;
  • Chawla M, Betcherman G, Banerji A. From red to gray: The” Third Transition” of aging populations in Eastern Europe and the former Soviet Union. Washington DC: The World Bank Publications, 2007;
  • Jakovljevic MB. Resource allocation strategies in Southeastern European health policy. Eur J Health Econ 2013; 14: 153-9;
  • Ševo G, Despotovic N, Erceg P, et al. Aging in Serbia. Adv Gerontol 2009; 22: 553-7
  • Penev G. Recent trends in growth of population and its age structure in Serbia and other Balkan countries and prospects of population aging until the middle of the 21st century. Gerontologija 2011; 38: 7-28
  • World Health Organization. International Agency for Research on Cancer. European Cancer Observatory. France: IARC, 2012. Availabe at: (last accessed November 2014)
  • Jakovljevic MB. Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market. Farmeconomia. Health economics and therapeutic pathways 2014; 15: 27-32;
  • Kovacevic A, Dragojevic-Simic V, Rancic N, et al. End-of-life costs of medical care for advanced stage cancer patients. Vojnosanit Pregl 2015; 72 [In press]
  • Comert H, Colak MS. Can Financial Stability be Maintained in Developing Countries after the Global Crisis: The Role of External Financial Shocks? ERC-Economic Research Center. Working Paper No. 1411. ERC-Economic Research Center, Middle East Technical University: Ankara, 2014
  • Rankovic A, Rancic N, Jovanovic M, et al. Impact of imaging diagnostics on the budget – Are we spending too much? Vojnosanit Pregl 2013; 70: 709-11
  • Jakovljevic M, Ranković A, Rančić N, et al. Radiology Services Costs and Utilization Patterns Estimates in Southeastern Europe – A Retrospective Analysis from Serbia. Value in Health Regional Issues 2013; 2: 218-25;
  • Jakovljevic M, Gutzwiller F, Schwenkglenks M, et al. Costs differentials among monoclonal antibodies-based first-line oncology cancer treatment protocols for breast cancer, colorectal Carcinoma and non-Hodgkin’s lymphoma. JBUON 2014; 19: 1111-20
  • Jakovljevic M, Zugic A, Rankovic A, et al. Radiation therapy remains the key cost driver of oncology inpatient treatment. J Med Econ 2015; 18: 29-36;
  • Yamagishi A, Morita T, Kawagoe S, Shimizu M, Ozawa T, An E, et al. Length of home hospice care, family-perceived timing of referrals, perceived quality of care, and quality of death and dying in terminally ill cancer patients who died at home. Support Care Cancer 2015; 23: 491-9;
  • Jakovljevic M, Jovanović M, Lazić Z, et al. Current efforts and proposals to reduce healthcare costs in Serbia. SJECR 2011; 2: 161-3
  • Pavlova M, Arsenijevic J, Groot W, et al. Projection of health service consumption and patient payment revenues in Central and Eastern European countries using system dynamics modelling. Soc Econ 2012; 34: 359-79;
  • Stojilković J. Growing number of pensioners and population aging in Serbia. Journal of the Geographical Institute “Jovan Cvijić” SASA 2011; 61: 69-84;


Abstract: 1395 views
HTML: 817 views
PDF: 295 views


  • There are currently no refbacks.